Kniha momentálne nie je na sklade

Parametre
- Počet strán
- 236 stránok
- Čas čítania
- 9 hodin
Viac o knihe
The book provides a comprehensive review of Parkinson's disease from both clinical and scientific perspectives, covering its preclinical course, symptomatology, and genetic factors. It explores various subtypes and their implications for pathology, alongside diagnostic tools and treatment strategies, including traditional and novel therapies focused on neuroprotection and neuroregeneration. A significant highlight is the discussion on budipine, a new antiparkinsonian drug that affects non-dopaminergic systems. The text emphasizes the ongoing challenges and unanswered questions in effectively treating Parkinson's disease.
Nákup knihy
Diagnosis and Treatment of Parkinsons Disease State of the Art, Horst Przuntek, Thomas Müller
- Jazyk
- Rok vydania
- 1999
- product-detail.submit-box.info.binding
- (mäkká)
Akonáhle sa objaví, pošleme vám e-mail.
Doručenie
Platobné metódy
Navrhnúť zmenu
- Titul
- Diagnosis and Treatment of Parkinsons Disease State of the Art
- Jazyk
- anglicky
- Autori
- Horst Przuntek, Thomas Müller
- Vydavateľ
- Springer Vienna
- Rok vydania
- 1999
- Väzba
- mäkká
- Počet strán
- 236
- ISBN13
- 9783211832752
- Anotácia
- The book provides a comprehensive review of Parkinson's disease from both clinical and scientific perspectives, covering its preclinical course, symptomatology, and genetic factors. It explores various subtypes and their implications for pathology, alongside diagnostic tools and treatment strategies, including traditional and novel therapies focused on neuroprotection and neuroregeneration. A significant highlight is the discussion on budipine, a new antiparkinsonian drug that affects non-dopaminergic systems. The text emphasizes the ongoing challenges and unanswered questions in effectively treating Parkinson's disease.